Pulse Biosciences Inc (PLSE) Stock Analysis

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $19.29
• Market Cap: $958.23M
• EPS: $-1.14
• 52-Week High: $26.30
• 52-Week Low: $12.56

Market Sentiment

Pulse Biosciences Inc currently has a Neutral sentiment score of -0.00.

About Pulse Biosciences Inc

Pulse Biosciences, Inc. is a pioneering bioelectrical medicine company headquartered in Hayward, California, dedicated to advancing therapeutic options through its proprietary Nano-Pulse Stimulation (NPS) technology. This innovative platform aims to provide non-invasive treatments that effectively disrupt cellular processes to promote healing across various medical fields, including dermatology and oncology. By addressing significant unmet medical needs, Pulse Biosciences is well-positioned f...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pulse Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PLSE pay dividends?

Pulse Biosciences Inc (PLSE) does not currently pay a regular dividend.

What is PLSE's market cap?

Pulse Biosciences Inc (PLSE) has a market capitalization of $958.23M with a current stock price of $19.29.